We are live on ! Find out more
CDIO icon

Cardio Diagnostics
CDIO

14 hedge funds and large institutions have $4.12M invested in Cardio Diagnostics in 2023 Q4 according to their latest regulatory filings, with 5 funds opening new positions, 3 increasing their positions, 2 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

2,607% more capital invested

Capital invested by funds: $152K → $4.12M (+$3.97M)

50% more repeat investments, than reductions

Existing positions increased: 3 | Existing positions reduced: 2

0.14% more ownership

Funds ownership: 0.13% → 0.27% (+0.14%)

0% more funds holding

Funds holding: 14 → 14 (0)

0% more first-time investments, than exits

New positions opened: 5 | Existing positions closed: 5

Holders
14
Holders Change
–
Holders Change %
0%
% of All Funds
0.2%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
5
Increased
3
Reduced
2
Closed
5
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
+$1.23M
2
Vanguard Group
Vanguard Group
Pennsylvania
+$194K
3
Geode Capital Management
Geode Capital Management
Massachusetts
+$72.6K
4
Northern Trust
Northern Trust
Illinois
+$53.2K
5
Squarepoint
Squarepoint
New York
+$45.1K

Top Sellers

Rank Fund Capital Flow
1
PCM
Prelude Capital Management
New York
-$41.1K
2
TSS
Two Sigma Securities
New York
-$11K
3
TRCT
Tower Research Capital (TRC)
New York
-$7.99K
4
Renaissance Technologies
Renaissance Technologies
New York
-$6K
5
HF
HRT Financial
New York
-$3K
Name Holding Trade Value Shares
Change 		Change in
Stake
BlackRock
1
BlackRock
New York
$2.66M +$1.23M +35,569 New
Vanguard Group
2
Vanguard Group
Pennsylvania
$578K +$194K +5,604 +263%
Geode Capital Management
3
Geode Capital Management
Massachusetts
$345K +$72.6K +2,098 +83%
Northern Trust
4
Northern Trust
Illinois
$115K +$53.2K +1,537 New
LA
5
Linden Advisors
New York
$114K – – –
PNC Financial Services Group
6
PNC Financial Services Group
Pennsylvania
$101K – – –
Squarepoint
7
Squarepoint
New York
$97.4K +$45.1K +1,304 New
State Street
8
State Street
Massachusetts
$50K – – –
Vontobel Holding
9
Vontobel Holding
Switzerland
$30.1K +$13.8K +400 New
CSC
10
Caldwell Sutter Capital
California
$20.2K – – –
WAM
11
Wolverine Asset Management
Illinois
$8.9K -$1.42K -41 -26%
TRCT
12
Tower Research Capital (TRC)
New York
$6.92K -$7.99K -231 -71%
Osaic Holdings
13
Osaic Holdings
Arizona
$1.25K +$588 +17 New
Wells Fargo
14
Wells Fargo
California
$291 +$69 +2 +100%
PCM
15
Prelude Capital Management
New York
– -$41.1K -4,033 Closed
TSS
16
Two Sigma Securities
New York
– -$11K -1,075 Closed
Renaissance Technologies
17
Renaissance Technologies
New York
– -$6K -593 Closed
HF
18
HRT Financial
New York
– -$3K -376 Closed
UBS Group
19
UBS Group
Switzerland
– -$21 -2 Closed
JP Morgan Chase
20
JP Morgan Chase
New York
– -$2 – –

CDIO Hedge Fund Activity: Q4 2023 in Review

14 of the 6,863 institutional investors tracked by Wall St. Rank reported a position in Cardio Diagnostics (CDIO) for Q4 2023, worth a combined $4.12M — up 2,607% from $152K a quarter earlier.

Fund positioning in CDIO was balanced in Q4 2023: 5 funds opened new positions, 5 closed out, 3 added to existing stakes and 2 trimmed.

The largest buyer was BlackRock, opening a new position worth an estimated $1.23M. The largest seller was Prelude Capital Management, exiting entirely with an estimated $41.1K sold.

  • 14 institutional investors held Cardio Diagnostics (CDIO) as of Q4 2023, unchanged from Q3 2023.
  • Funds reported $4.12M of Cardio Diagnostics stock for Q4 2023, up 2,607% quarter-over-quarter.
  • 5 funds opened new Cardio Diagnostics positions in Q4 2023 and 5 closed out, a net change of 0 holders.
  • The largest Cardio Diagnostics buyer in Q4 2023 was BlackRock, an estimated $1.23M added.
  • The largest Cardio Diagnostics seller in Q4 2023 was Prelude Capital Management, an estimated $41.1K sold.

Based on aggregated 13F filings for Q4 2023.